Citadel Advisors’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
13,768
+454
| +3% | +$4.12K | ﹤0.01% | 5181 |
|
|
2025
Q1 | $127K | Buy |
+13,314
| New | +$127K | ﹤0.01% | 5057 |
|
|
2023
Q2 | – | Sell |
-10,354
| Closed | -$143K | – | 6040 |
|
|
2023
Q1 | $143K | Buy |
+10,354
| New | +$143K | ﹤0.01% | 4770 |
|
|
2022
Q3 | – | Sell |
-17,657
| Closed | -$150K | – | 6189 |
|
|
2022
Q2 | $150K | Buy |
+17,657
| New | +$150K | ﹤0.01% | 5120 |
|
|
2021
Q2 | – | Sell |
-7,114
| Closed | -$243K | – | 6649 |
|
|
2021
Q1 | $243K | Buy |
+7,114
| New | +$243K | ﹤0.01% | 5240 |
|